We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Nat.west 9%pf | LSE:NWBD | London | Bond |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.15 | 0.11% | 141.65 | 140.30 | 143.00 | 141.65 | 141.65 | 141.65 | 0 | 08:00:00 |
Hot Features
Premium
RNS Number : 7325F
Medical Marketing Int'l Group PLC
13 October 2008
Notification of Major Interest in Shares
Monday 13 October 2008 - Medical Marketing International Group plc ("MMI" or the "Company") (AIM:MMG), the life sciences company focused
on the development of drugs for cancer, received notification on 13 October 2008 from The Royal Bank of Scotland Group plc, that as at 9
October 2008, ABN AMRO Bank N.V (2.20%) and National Westminster Bank Plc (0.05%) have, in aggregate, decreased their interest from
1,811,250 to 1,431,250 ordinary shares of 0.2p each of the Company. The combined holding represents 2.25% of the Company's issued share
capital of 63,665,557 ordinary shares.
Enquiries:
Medical Marketing International Group plc
Phil Cartmell, Non-executive Chairman Tel: +44 (0) 1223 477 677
Mark Burton, Chief Technical Officer
Rob Sprawson, Chief Financial Officer
FinnCap
Sam Smith/Charlie Cunningham Tel: +44 (0)20 7600 1658
Financial Dynamics
David Yates/Emma Thompson Tel: +44 (0)20 7831 3113
About MMI
Medical Marketing International Group plc ("MMI") is a life sciences company that identifies, acquires and develops world-class
compounds and technologies for the treatment of cancer. The Company manages the preclinical and early clinical development of drug
candidates before pursuing licensing partners to manage late-stage development. Please visit www.mmigroup.co.uk for further information.
Notwithstanding the inclusion on this release by MMI of a website address and/or another electronic address, MMI does not accept any
notices or any other documents or communication via its website or other electronic address. All such notices, documents or communication
shall be in hard copy format only. Accordingly the provisions of section 333 Companies Act 2006 allowing persons to communicate with MMI
electronically shall not apply to MMI.
-ends-
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLMJBITMMABBMP
1 Year Nat.west 9%pf Chart |
1 Month Nat.west 9%pf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
